Guardion Health: Jumps on deal with Malaysian company for immuno-supportive formula
** Shares of medical device maker GHSI.O jump 8.5% to 32
cents premarket
** Company says a Malaysia's Ho Wah Genting Berhad HOWA.KL
has selected it to develop a new formula designed to enhance the
immune system urn:newsml:reuters.com:*:nGNX4J95TL
** GHSI says the formula has not been used nor tested, and
is not intended to specifically address symptoms of the
coronavirus
** Formula to provide both immuno-supportive and
anti-inflammatory benefits - GHSI
** Up to Tuesday's close, stock had fallen ~91% since its
IPO in April
(Reporting by Dania Nadeem in Bengaluru)
((Dania.Nadeem@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3463;))
Recent news on Guardion Health Sciences
See all newsBrief: Guardion Health Sciences Announces Termination Of CEO, Effective October 17
Brief: Guardion Health Sciences Announces Completion Of Sale Of Its Viactiv® Brand And Business To Doctor’S Best Inc. And Stockholder Approval Of Plan Of Liquidation And Dissolution
Brief: Guardion Health Sciences Announces Its Largest Stockholder Has Voted In Favor Of Proposals To Sell The Viactiv Business
Guardion Health Sciences Inc reports results for the quarter ended in March - Earnings Summary
Guardion Health Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview